YU402A - Novi derivati 2,3-benzodiazepina - Google Patents

Novi derivati 2,3-benzodiazepina

Info

Publication number
YU402A
YU402A YU402A YUP402A YU402A YU 402 A YU402 A YU 402A YU 402 A YU402 A YU 402A YU P402 A YUP402 A YU P402A YU 402 A YU402 A YU 402A
Authority
YU
Yugoslavia
Prior art keywords
bond
positions
hydrogen
lower alkyl
present
Prior art date
Application number
YU402A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Zoltan Greff
Geza Szabo
Jozsef Barkoczy
Zoltan Ratkai
Gabor Blasko
Gyula Simlg
Gabor Gigler
Marko Bernadett Martonne
Gyorgy Levay
Karoly Tihanyi
Andras Egyed
Annamaria Simo
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of YU402A publication Critical patent/YU402A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
YU402A 1999-07-07 2000-07-04 Novi derivati 2,3-benzodiazepina YU402A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9902291A HU227128B1 (en) 1999-07-07 1999-07-07 New 2,3-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
YU402A true YU402A (sh) 2004-11-25

Family

ID=89998666

Family Applications (1)

Application Number Title Priority Date Filing Date
YU402A YU402A (sh) 1999-07-07 2000-07-04 Novi derivati 2,3-benzodiazepina

Country Status (22)

Country Link
US (1) US7053082B1 (sk)
EP (1) EP1200442B8 (sk)
JP (1) JP2003504372A (sk)
KR (1) KR100818001B1 (sk)
CN (1) CN1162432C (sk)
AT (1) ATE243699T1 (sk)
AU (1) AU5836300A (sk)
BG (1) BG65405B1 (sk)
CA (1) CA2378305A1 (sk)
CZ (1) CZ20014698A3 (sk)
DE (1) DE60003561T2 (sk)
DK (1) DK1200442T3 (sk)
HK (1) HK1047581B (sk)
HR (1) HRP20020015B1 (sk)
HU (1) HU227128B1 (sk)
PL (1) PL351839A1 (sk)
RO (1) RO121853B1 (sk)
RU (1) RU2243228C2 (sk)
SK (1) SK286680B6 (sk)
UA (1) UA72261C2 (sk)
WO (1) WO2001004122A2 (sk)
YU (1) YU402A (sk)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225100B1 (hu) * 2000-12-21 2006-06-28 Egyt Gyogyszervegyeszeti Gyar 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
CA2633804A1 (en) * 2005-12-30 2007-07-12 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
FR2972454B1 (fr) * 2011-03-08 2013-03-01 Servier Lab Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU195788B (en) * 1986-05-21 1988-07-28 Gyogyszerkutato Intezet Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására
DE4428835A1 (de) * 1994-08-01 1996-02-08 Schering Ag Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
CA2198751C (en) * 1994-08-31 2006-07-11 Benjamin Alan Anderson Dihydro-2,3-benzodiazepine derivatives
US5891871A (en) * 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування

Also Published As

Publication number Publication date
ATE243699T1 (de) 2003-07-15
CA2378305A1 (en) 2001-01-18
PL351839A1 (en) 2003-06-16
RO121853B1 (ro) 2008-06-30
KR100818001B1 (ko) 2008-03-31
WO2001004122A3 (en) 2001-05-10
SK286680B6 (sk) 2009-03-05
BG65405B1 (bg) 2008-06-30
DE60003561D1 (de) 2003-07-31
US7053082B1 (en) 2006-05-30
HUP9902291A2 (hu) 2001-12-28
BG106281A (en) 2003-01-31
EP1200442A1 (en) 2002-05-02
DE60003561T2 (de) 2004-04-29
HK1047581A1 (en) 2003-02-28
CN1370174A (zh) 2002-09-18
AU5836300A (en) 2001-01-30
EP1200442B8 (en) 2003-08-20
KR20020022765A (ko) 2002-03-27
CZ20014698A3 (cs) 2002-06-12
HU227128B1 (en) 2010-07-28
HRP20020015B1 (en) 2005-02-28
WO2001004122A2 (en) 2001-01-18
HK1047581B (zh) 2004-04-30
SK172002A3 (en) 2002-06-04
CN1162432C (zh) 2004-08-18
UA72261C2 (uk) 2005-02-15
HU9902291D0 (en) 1999-09-28
JP2003504372A (ja) 2003-02-04
HRP20020015A2 (en) 2004-08-31
DK1200442T3 (da) 2003-10-20
RU2243228C2 (ru) 2004-12-27
EP1200442B1 (en) 2003-06-25

Similar Documents

Publication Publication Date Title
EP1074542A4 (en) SULFONAMID CONTAINING INDOLDER DERIVATIVES
CA2316902A1 (en) Alpha-aminoamide derivatives useful as analgesic agents
TW341565B (en) Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them
HU9602466D0 (en) Naphthalene derivatives as prostaglandin i2 agonits
NZ330973A (en) Azolobenzazepine derivatives as neurologically active agents
NZ514662A (en) Amine derivatives
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
BG104069A (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
MX9806171A (es) Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
AU626980B2 (en) Tetrahydrobenzimidazole derivatives
EP0924207A4 (en) CHROMENE-3-CARBOXYLATE DERIVATIVES
HUP0004477A2 (hu) Herbicid hatású 3-(1,2-benzizotiazol- vagy-izoxazol-5-il)-csoporttal helyettesített pirimidinszármazékok, intermedierjeik, előállításuk és alkalmazásuk
HUP0203645A2 (hu) Fenilpiperazinil-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2002000638A3 (en) Substituted phthalides as anti-convulsive drugs
YU402A (sh) Novi derivati 2,3-benzodiazepina
MY131762A (en) Pharmaceutical compounds
PL337188A1 (en) Derivatives of 17beta - allyloxy (thio) alkyl - androstane for modulation of meiosis
AU686934B2 (en) 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
AU2002214320A1 (en) Imidazole derivatives, process for their preparation and their use
AU3285000A (en) 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
TW340844B (en) Amide derivatives
ATE216368T1 (de) Heterocyclische carboxyalkylderivate
AU3648093A (en) Pyrrolidine derivatives useful as 5-HT3-antagonists
HU9602534D0 (en) Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
BG103937A (en) 5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and application in therapy